Whereas the majority of described osteoclast-derived molecules act by enhancing bone formation, Semaphorin 4D (SEMA4D) is one of the few known to suppress bone formation, and it is the only one that has also been implicated in tumour progression [14, 32, 33]. Here, SEMA4D is linked to neoplasm.